Management of the Menopause with Hormone Implants

1. Greenblatt RB Buran RR Indication for hormone pellets in the therapy of endocrine and gynaecological disorders. Am J Obstet Gynaeol 1949; S7: 294–301

2. Cardozo LD Gibb DMF Studd JWW The effects of subcutaneous hormone implants during the climacteric. Maturitas 1984; 5: 177–184

3. Garnett T Studd JWW Wilson N Savvas MA A cross sectional study of the effects of long term percutaneous hormone replacement therapy on bone density. Obstet and Gynaecol 1991; 78: 6: 1002–1007

4. Studd JWW Whitehead MI The Menopause. Blackwell Scientific Publications 1988, p. 123

5. Whitehead M Godfree V. Hormone Replacement Therapy; Your Questions Answered. 1992, p. 122

6. Studd JWW Magos M. Hormone pellet implantation for the menopause and pre-menstrual syndrome. Obstetrics and Gynaecology Clinics of North America 1978; 14: 229–250.

7.8.9. Whitehead M Godfree V. Hormone Replacement Therapy: Your Questions Answered. 1992, p. 116, 104, 200, 201, 106

10. Studd JWW Holland EF The dose response of percutaneous oestradiol implants on the skeletons of postmenopausal women. Br J Obstet Gynaecol 1994; 101: 787–791

11. British National Formulary 1995

12. Garnett T Studd JWW Hormone implants and tachyphylaxis. Br J Obstet Gynaecol 1990; 97: 917–921.

13. Whitehead M Godfree V. Hormone Replacement Therapy; Your Questions Answered. 1992, p. 105–6

14. Ganger K Cust M Whitehead MI Symptoms of oestrogen deficiency associated with supraphysiological plasma oestradiol concentrations in women with oestradiol implants. Br Med J 1989; 299: 601–2